{
    "ticker": "AAPG",
    "name": "Ascentage Pharma Group International American Depository Shares",
    "market": "stocks",
    "locale": "us",
    "primary_exchange": "XNAS",
    "type": "ADRC",
    "active": true,
    "currency_name": "usd",
    "cik": "0002023311",
    "composite_figi": "BBG01RJXM9C9",
    "share_class_figi": "BBG01RJXMB89",
    "market_cap": 1628146261.5,
    "description": "Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.",
    "ticker_root": "AAPG",
    "homepage_url": "https://www.ascentagepharma.com",
    "total_employees": 574,
    "list_date": "2025-01-24",
    "branding": {
        "logo_url": "https://api.polygon.io/v1/reference/company-branding/YXNjZW50YWdlcGhhcm1hLmNvbQ/images/2025-03-20_logo.svg",
        "icon_url": "https://api.polygon.io/v1/reference/company-branding/YXNjZW50YWdlcGhhcm1hLmNvbQ/images/2025-03-20_icon.jpeg"
    },
    "share_class_shares_outstanding": 348270000,
    "weighted_shares_outstanding": 87066645,
    "round_lot": 100
}